
Fortress Biotech, Inc.: shareholders and insiders
Price
$1.82
November 17, 2026Market cap $57M
What Ploutos Investor adds for Fortress Biotech
Part of Ploutos Investor, €9.99 a month
- The full history: 13 fiscal years, from 2013
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The reported profit is far larger than a business usually earns on its market value, which usually means one-off or accounting gains. We leave out the P/E and the earnings yield.
- The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.
- A figure that did not match the numbers it is built from has been left out.
Insiders and their shares
Purchases and sales by officers and directors from Nov 18, 2025 to Oct 1, 2026, from their own Form 4 filings.
Bought on the market
–
nobody
Sold on the market
–
nobody
From Nov 18, 2025 to Nov 18, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
No sales in the period.
From the Form 4s insiders file with the SEC within two business days of each trade.
Insiders and their shares
Every buy and sale by FBIO's officers and directors from 2011 up to November 17, 2025, 15 more calendar years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 3 years.
and 10 more, back to 2011
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- Lindsay A. Rosenwald, M.D.Share of class20.7%
- Highbridge Capital Management, LLCShare of class7.80%
- Integrated Core Strategies (US) LLCwith 3 more personsShare of class6.50%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Lindsay A. Rosenwald, M.D. | 20.7% | 6.92M | Mar 20, 2026 | 13D/A | |
| Highbridge Capital Management, LLC | 7.80% | 2.73M | May 15, 2026 | 13G/A | |
| Integrated Core Strategies (US) LLCwith 3 more persons | 6.50% | 2.17M | Oct 29, 20262 filings since Sep 1, 2026 | 13G/A |
What the holders on a 13D state as their purpose
From Item 4 of the filing, in the holder's own words. It is the intention the holder states, not something that happened.
Lindsay A. Rosenwald, M.D.20.7%From the filing of Mar 20, 2026
The Reporting Person was granted the shares of Common Stock on each of January 1, 2025 and March 18, 2026 pursuant to the LTIP and Award Agreement and upon the determination that the Reporting Person had achieved 100% of the relevant goals and objectives established by the Compensation Committee of the Issuer's Board. The Reporting Person does not have any present plans or proposals that relate to or would result in: (i) the acquisition by any person of additional securities of Issuer, or the disposition of securities of Issuer; (ii) an extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving Issuer or any of Issuer's subsidiaries; (iii) a sale or…
From the filing of Mar 20, 2026
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Citadel Advisors (Griffin)In the quarter-57%
- Renaissance TechnologiesIn the quarter
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Citadel Advisors (Griffin) | 77.1K | -57% | $200.0K | 0.00% |
| Renaissance Technologies | – | – | 0.00% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 14.4% of its shares outstanding were held short, -7.7% since the report before.
- Shares held short
- 4.52M
- 14.4%
- Since the report before4.90M on Sep 30, 2026
- -7.7%
- 16.1
- 281.0K
- More days to cover thanof 4,578 US-listed companies with enough volume
- 98%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 169.9K
- Nov 15, 2023: Shares held short 259.8K
- Nov 30, 2023: Shares held short 618.0K
- Dec 15, 2023: Shares held short 907.4K
- Dec 29, 2023: Shares held short 1.13M
- Jan 12, 2024: Shares held short 1.29M
- Jan 31, 2024: Shares held short 1.49M
- Feb 15, 2024: Shares held short 1.64M
- Feb 29, 2024: Shares held short 1.54M
- Mar 15, 2024: Shares held short 1.73M
- Mar 28, 2024: Shares held short 1.88M
- Apr 15, 2024: Shares held short 1.82M
- Apr 30, 2024: Shares held short 1.75M
- May 15, 2024: Shares held short 1.67M
- May 31, 2024: Shares held short 1.61M
- Jun 14, 2024: Shares held short 1.54M
- Jun 28, 2024: Shares held short 1.66M
- Jul 15, 2024: Shares held short 1.48M
- Jul 31, 2024: Shares held short 1.59M
- Aug 15, 2024: Shares held short 1.61M
- Aug 30, 2024: Shares held short 1.72M
- Sep 13, 2024: Shares held short 2.17M
- Sep 30, 2024: Shares held short 2.35M
- Oct 15, 2024: Shares held short 2.57M
- Oct 31, 2024: Shares held short 2.62M
- Nov 15, 2024: Shares held short 2.92M
- Nov 29, 2024: Shares held short 2.82M
- Dec 13, 2024: Shares held short 3.11M
- Dec 31, 2024: Shares held short 3.40M
- Jan 15, 2025: Shares held short 3.48M
- Jan 31, 2025: Shares held short 3.58M
- Feb 14, 2025: Shares held short 3.69M
- Feb 28, 2025: Shares held short 3.68M
- Mar 14, 2025: Shares held short 3.77M
- Mar 31, 2025: Shares held short 3.63M
- Apr 15, 2025: Shares held short 3.63M
- Apr 30, 2025: Shares held short 3.69M
- May 15, 2025: Shares held short 3.51M
- May 30, 2025: Shares held short 3.36M
- Jun 13, 2025: Shares held short 3.29M
- Jun 30, 2025: Shares held short 3.20M
- Jul 15, 2025: Shares held short 3.13M
- Jul 31, 2025: Shares held short 2.98M
- Aug 15, 2025: Shares held short 2.79M
- Aug 29, 2025: Shares held short 3.03M
- Sep 15, 2025: Shares held short 3.79M
- Sep 30, 2025: Shares held short 3.75M
- Oct 15, 2025: Shares held short 3.38M
- Oct 31, 2025: Shares held short 3.51M
- Nov 14, 2025: Shares held short 3.98M
- Nov 28, 2025: Shares held short 3.71M
- Dec 15, 2025: Shares held short 3.62M
- Dec 31, 2025: Shares held short 4.05M
- Jan 15, 2026: Shares held short 4.49M
- Jan 30, 2026: Shares held short 4.58M
- Feb 13, 2026: Shares held short 4.31M
- Feb 27, 2026: Shares held short 4.48M
- Mar 13, 2026: Shares held short 4.28M
- Mar 31, 2026: Shares held short 4.36M
- Apr 15, 2026: Shares held short 4.55M
- Apr 30, 2026: Shares held short 4.65M
- May 15, 2026: Shares held short 4.88M
- May 29, 2026: Shares held short 5.09M
- Jun 15, 2026: Shares held short 5.14M
- Jun 30, 2026: Shares held short 5.31M
- Jul 15, 2026: Shares held short 5.38M
- Jul 31, 2026: Shares held short 5.78M
- Aug 14, 2026: Shares held short 5.58M
- Aug 31, 2026: Shares held short 5.44M
- Sep 15, 2026: Shares held short 5.11M
- Sep 30, 2026: Shares held short 4.90M
- Oct 15, 2026: Shares held short 4.52M
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading56.7% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 56.7% of the shares in the reported trades were short sales, against 35.4% in the 14 before.
- Last 14 sessionsOct 29, 2026 – Nov 17, 2026
- 56.7%
- The 14 beforeOct 9, 2026 – Oct 28, 2026
- 35.4%
- Change
- +21.3 pts
- Short sales a dayon average, of 141.6K shares
- 80.3K
- More than atof 3,666 US-listed companies, same days
- 73%
- Median of alleight in ten from 34.6% to 63.7%
- 50.3%
- Short sales
- Oct 9, 2026: Short sales 22.1%
- Oct 12, 2026: Short sales 29.6%
- Oct 13, 2026: Short sales 35.8%
- Oct 14, 2026: Short sales 24.1%
- Oct 15, 2026: Short sales 32.7%
- Oct 16, 2026: Short sales 36.3%
- Oct 19, 2026: Short sales 73.6%
- Oct 20, 2026: Short sales 25.6%
- Oct 21, 2026: Short sales 36.5%
- Oct 22, 2026: Short sales 27.2%
- Oct 23, 2026: Short sales 40.6%
- Oct 26, 2026: Short sales 48.4%
- Oct 27, 2026: Short sales 36.9%
- Oct 28, 2026: Short sales 30%
- Oct 29, 2026: Short sales 61.4%
- Oct 30, 2026: Short sales 52.9%
- Nov 2, 2026: Short sales 53.5%
- Nov 3, 2026: Short sales 37.2%
- Nov 4, 2026: Short sales 41.9%
- Nov 5, 2026: Short sales 59.1%
- Nov 6, 2026: Short sales 33.5%
- Nov 9, 2026: Short sales 59.1%
- Nov 10, 2026: Short sales 50.9%
- Nov 11, 2026: Short sales 82.7%
- Nov 12, 2026: Short sales 52.2%
- Nov 13, 2026: Short sales 41.5%
- Nov 16, 2026: Short sales 58.4%
- Nov 17, 2026: Short sales 54.3%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
- Lindsay A Md RosenwaldPRESIDENT, CEO & CHAIRMANDirectly3.66M
- David JinChief Financial OfficerDirectly1.65M
- Dov KleinDirectorDirectly53.4K
| Person | Directly | Indirectly | After the trade of | Filing |
|---|---|---|---|---|
| Lindsay A Md RosenwaldPRESIDENT, CEO & CHAIRMAN | 3.66M | – | Sep 23, 2024 | Form 4 |
| David JinChief Financial Officer | 1.65M | – | Oct 1, 2026 | Form 4 |
| Dov KleinDirector | 53.4K | – | May 20, 2024 | Form 4 |
A lower bound: it counts only the 3 officers and directors with a market trade since Nov 19, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
The ETFs that hold it
Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- IWCiShares Micro-Cap ETFWeight in the fund0.02%
- VXFVanguard Extended Market Index FundWeight in the fund0.00%
- VTIVanguard Total Stock Market Index FundWeight in the fund0.00%
| ETF | Weight in the fund | Holdings as of |
|---|---|---|
| IWCiShares Micro-Cap ETF | 0.02% | Jun 30, 2026 |
| VXFVanguard Extended Market Index Fund | 0.00% | Jun 30, 2026 |
| VTIVanguard Total Stock Market Index Fund | 0.00% | Jun 30, 2026 |
3 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 56
- Q4 2025: Managers 52
- Q1 2026: Managers 53
- Q2 2026: Managers 55
Institutional investors by quarter
The fund managers holding FBIO, quarter by quarter, from Q1 2015 to Q2 2025, 42 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 55 managers held 5.84M shares, worth $18M. During the quarter 13 opened a position, 11 closed one, 12 added and 18 trimmed.
The largest holders, Q2 2026
- Vanguard Capital ManagementIn the quarter+7.4%
- Opaleye ManagementIn the quarter-15%
- Mackenzie FinancialIn the quarter
- Gsa Capital PartnersIn the quarter+80%
- Shikiar Asset ManagementIn the quarter
- Geode Capital ManagementIn the quarter+3.5%
- BlackRockIn the quarter+14%
- Two Sigma InvestmentsIn the quarter+8.6%
- Bridgeway Capital ManagementIn the quarter-2.7%
- Vanguard Fiduciary TrustIn the quarter+17%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| Vanguard Capital Management | 1.04M | +7.4% | $3.2M |
| Opaleye Management | 890.0K | -15% | $2.7M |
| Mackenzie Financial | 555.7K | $1.7M | |
| Gsa Capital Partners | 458.5K | +80% | $1.4M |
| Shikiar Asset Management | 305.5K | $935.0K | |
| Geode Capital Management | 300.5K | +3.5% | $919.9K |
| BlackRock | 224.8K | +14% | $687.8K |
| Two Sigma Investments | 213.8K | +8.6% | $654.2K |
| Bridgeway Capital Management | 177.4K | -2.7% | $542.7K |
| Vanguard Fiduciary Trust | 166.4K | +17% | $509.1K |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do Fortress Biotech's filings show?
Who buys and sells is one part of Fortress Biotech's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have FBIO's insiders bought or sold?
From Jun 24, 2026 to Oct 1, 2026 Fortress Biotech's insiders reported no purchase or sale of shares on the market.
Which well-known managers hold FBIO?
2 of the managers we track held the shares on Sep 30, 2026. The largest position was Citadel Advisors (Griffin)'s, worth $200.0K.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.